What’s new

• Standalone revenue rose 11% to ₹255.37 crore for FY26.
• Net profit fell to ₹14.75 crore from ₹15.89 crore in FY25.
• Board recommended a dividend of ₹0.05 per share.

Why it matters

The results are routine and match previously shared unaudited figures. For a company of this size, the lack of surprises is the primary takeaway.

What we’re watching

• Any updates on the previously disclosed preference share redemption.
• Future margin trends given the slight profit decline.
• Dividend payout consistency.

The full read

Jaysynth Orgochem just released its audited results for the year ended March 31, 2026. The company reached ₹255.37 crore in standalone revenue, marking an 11% increase over the previous year.

Despite this top-line growth, net profit dipped to ₹14.75 crore from ₹15.89 crore in the prior period. These figures align perfectly with previously reported unaudited data, confirming a stable performance for the ₹163 crore market-cap firm. The board recommended a dividend of ₹0.05 per share, and the auditor provided an unmodified opinion on the financials. It is a routine annual disclosure with no material surprises or deviations from prior guidance. Nothing changed.

Primary source: BSE · NSE

What’s new

• Jaysynth Orgochem is incorporating a wholly owned subsidiary in Hong Kong.
• The new entity will support international trading and export activities.
• The board recommended a 5% dividend on equity shares and 2% on preference shares.

Why it matters

For a company with a market cap of ₹163 crore, the move into Hong Kong signals a shift toward direct international presence. It replaces third-party channels with a dedicated entity to capture export value. This is a small-scale expansion that changes the company's operational structure.

What we’re watching

• The timeline for the Hong Kong subsidiary to become operational.
• Any disclosure on the capital allocation required for the new entity.
• Shareholder approval for the proposed dividend at the upcoming AGM.

The full read

Jaysynth Orgochem is expanding its international reach. The board approved the incorporation of a wholly owned subsidiary in Hong Kong to support the company's trading and export activities. For a firm with a market capitalization of ₹163 crore, this move formalizes its presence in global markets. The board also recommended a dividend of ₹0.05 per equity share, or 5% on the ₹1 face value, and a 2% payout on its redeemable non-convertible preference shares. These payouts await shareholder approval at the upcoming annual general meeting. The company released its audited standalone and consolidated results for the year ended March 31, 2026. The creation of the Hong Kong entity indicates the company's intent to capture more value from its export operations directly.

Primary source: BSE · NSE